Suchergebnisse - "Tamura, Tomohide"

PubPharm (29)

1

Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall Phase

enthalten in: Advances in therapy | 2023

von Inui, N. | Toi, Y. | Yoneshima, Y. | +5

2

A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2019

von Hida, T. | Velcheti, V. | Reckamp, K. | +7

3

Multicenter, placebo-controlled, double-blind, randomized study of fosnetupitant in combination with palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy

enthalten in: Cancer | 2019

von Sugawara, S. | Inui, N. | Kanehara, M. | +10

4

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer : A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2019

von Watanabe, S. | Yoshioka, H. | Sakai, H. | +19

ErratumIn: Lung Cancer. 2019 Jun;132:157-158. - PMID 31014853

5

A dose-finding randomized Phase II study of oral netupitant in combination with palonosetron .75 mg intravenous for the prevention of chemotherapy-induced nausea and vomiting in Japanese patients receiving highly emetogenic chemotherapy

enthalten in: Japanese journal of clinical oncology | 2019

von Osaki, A. | Inoue, K. | Sakai, H. | +9

6

Randomized phase II trial of weekly dose-intensive chemotherapy or amrubicin plus cisplatin chemotherapy following induction chemoradiotherapy for limited-disease small cell lung cancer (JCOG1011)

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2017

von Sekine, I. | Harada, H. | Yamamoto, N. | +11

7

Three-Year Follow-Up of an Alectinib Phase I/II Study in ALK-Positive Non-Small-Cell Lung Cancer : AF-001JP

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2017

von Tamura, T. | Kiura, K. | Seto, T. | +14

8

Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer

enthalten in: Cancer science | 2017

von Hida, T. | Nishio, M. | Nogami, N. | +19

9

Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy

enthalten in: Investigational new drugs | 2017

von Tambo, Y. | Hosomi, Y. | Sakai, H. | +15

10

Phase I/II study of tecemotide as immunotherapy in Japanese patients with unresectable stage III non-small cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2017

von Katakami, N. | Hida, T. | Nokihara, H. | +9